Credit Suisse’s Immune Design Corp. IMDZ Stock Holding History

Credit Suisse’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,152	Closed	-$40K	–	4304
2018 Q1	$40K	Buy	+12,152	New	+$43K	﹤0.01%	3899
2017 Q4	–	Sell	-11,241	Closed	-$117K	–	4400
2017 Q3	$117K	Buy	+11,241	New	+$111K	﹤0.01%	4069
2016 Q4	–	Sell	-15,489	Closed	-$117K	–	4379
2016 Q3	$117K	Buy	15,489 +1,965	+15%	+$14.4K	﹤0.01%	3910
2016 Q2	$110K	Buy	+13,524	New	+$169K	﹤0.01%	4040

Other funds holding IMDZ

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse's IMDZ Position: Q2 2018 in Review

Credit Suisse sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 12,152 shares — an estimated $40K sold.

Credit Suisse first reported a position in IMDZ in Q2 2016 and held it in 4 quarters. The position peaked at $117K in Q3 2017. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.

Credit Suisse reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
Credit Suisse sold 12,152 Immune Design Corp. shares in Q2 2018, an estimated $40K.
Credit Suisse first reported a position in Immune Design Corp. in Q2 2016 and held it in 4 quarters.
Credit Suisse's Immune Design Corp. position peaked at $117K in Q3 2017.
80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.

Based on Credit Suisse's 13F filing for Q2 2018, filed 14 Aug 2018.